1134 related articles for article (PubMed ID: 15070264)
1. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
2. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
3. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.
Rivard MJ; Ballester F; Butler WM; DeWerd LA; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Papagiannis P
Med Phys; 2017 Sep; 44(9):e297-e338. PubMed ID: 28644913
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
5. Comment on "Update of AAPM Task Group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations" [Med. Phys. 31, 633-674 (2004)].
Meigooni AS; Rachabatthula V; Awan SB; Koona RA
Med Phys; 2005 Jun; 32(6):1820-1; author reply 1822-4. PubMed ID: 16013739
[No Abstract] [Full Text] [Related]
6. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
7. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.
DeWerd LA; Huq MS; Das IJ; Ibbott GS; Hanson WF; Slowey TW; Williamson JF; Coursey BM;
Med Phys; 2004 Mar; 31(3):675-81. PubMed ID: 15070265
[TBL] [Abstract][Full Text] [Related]
8. Supplement to the 2004 update of the AAPM Task Group No. 43 Report.
Rivard MJ; Butler WM; DeWerd LA; Huq MS; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Williamson JF;
Med Phys; 2007 Jun; 34(6):2187-205. PubMed ID: 17654921
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed.
Daskalov GM; Williamson JF
Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
12. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
Nath R; Yue N; Roa E
Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.
Mourtada F; Mikell J; Ibbott G
Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684
[TBL] [Abstract][Full Text] [Related]
14. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.
Perez-Calatayud J; Ballester F; Das RK; Dewerd LA; Ibbott GS; Meigooni AS; Ouhib Z; Rivard MJ; Sloboda RS; Williamson JF
Med Phys; 2012 May; 39(5):2904-29. PubMed ID: 22559663
[TBL] [Abstract][Full Text] [Related]
15. Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription.
Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Rivard MJ; Ibbott G
Med Phys; 2000 Apr; 27(4):634-42. PubMed ID: 10798683
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
Hedtjärn H; Carlsson GA; Williamson JF
Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
[TBL] [Abstract][Full Text] [Related]
18. Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry.
Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Ibbott G
Med Phys; 1999 Apr; 26(4):570-3. PubMed ID: 10227361
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional dosimetry in the near field of the model 200 103Pd source for interstitial brachytherapy implants using a thermoluminescent sheet.
Iwata K; Yue NJ; Nath R
Phys Med Biol; 2004 Sep; 49(17):4049-63. PubMed ID: 15470922
[TBL] [Abstract][Full Text] [Related]
20. Air-kerma strength determination of a new directional (103)Pd source.
Aima M; Reed JL; DeWerd LA; Culberson WS
Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
